US20160081694A1 - Vasculature Occlusion Device Detachment System With Tapered Corewire and Single Loop Fuse Detachment - Google Patents

Vasculature Occlusion Device Detachment System With Tapered Corewire and Single Loop Fuse Detachment Download PDF

Info

Publication number
US20160081694A1
US20160081694A1 US14/491,145 US201414491145A US2016081694A1 US 20160081694 A1 US20160081694 A1 US 20160081694A1 US 201414491145 A US201414491145 A US 201414491145A US 2016081694 A1 US2016081694 A1 US 2016081694A1
Authority
US
United States
Prior art keywords
fuse element
electrically conductive
heating fuse
corewire
accordance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US14/491,145
Other versions
US9855050B2 (en
Inventor
Juan A. Lorenzo
Robert Slazas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DePuy Synthes Products Inc
Original Assignee
DePuy Synthes Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DePuy Synthes Products Inc filed Critical DePuy Synthes Products Inc
Assigned to DePuy Synthes Products, LLC reassignment DePuy Synthes Products, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LORENZO, JUAN A., SLAZAS, ROBERT
Priority to US14/491,145 priority Critical patent/US9855050B2/en
Priority to BR102015023992A priority patent/BR102015023992A2/en
Priority to AU2015227530A priority patent/AU2015227530B2/en
Priority to CN201510599740.6A priority patent/CN105434004B/en
Priority to CA2904928A priority patent/CA2904928A1/en
Priority to EP20183939.6A priority patent/EP3738528A1/en
Priority to ES15185808T priority patent/ES2818105T3/en
Priority to KR1020150132174A priority patent/KR102525250B1/en
Priority to JP2015184845A priority patent/JP6768276B2/en
Priority to EP15185808.1A priority patent/EP2997911B1/en
Publication of US20160081694A1 publication Critical patent/US20160081694A1/en
Assigned to DePuy Synthes Products, Inc. reassignment DePuy Synthes Products, Inc. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: DePuy Synthes Products, LLC
Assigned to DePuy Synthes Products, Inc. reassignment DePuy Synthes Products, Inc. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: DePuy Synthes Products, LLC
Publication of US9855050B2 publication Critical patent/US9855050B2/en
Application granted granted Critical
Priority to JP2020107599A priority patent/JP6992130B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/12145Coils or wires having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/12154Coils or wires having stretch limiting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00535Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
    • A61B2017/00539Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated hydraulically
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00929Material properties isolating electrical current
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • A61B2017/12068Details concerning the detachment of the occluding device from the introduction device detachable by heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • A61B2017/1209Details concerning the detachment of the occluding device from the introduction device detachable by electrical current or potential, e.g. electroactive polymer

Definitions

  • the present invention relates to vasculature occlusive devices (e.g., embolic coils) for implantation within a blood vessel of a body.
  • the present invention relates to an improved heating detachment system for an embolic coil delivery system in the treatment of blood vessel disorders.
  • Vascular disorders and defects such as aneurysms and other arterio-venous malformations are especially difficult to treat when located near critical tissues or where ready access to malformation is not available. Both difficulty factors apply especially to cranial aneurysms. Due to the sensitive brain tissue surrounding cranial blood vessels and the restricted access, it is very challenging and often risky to surgically treat defects of the cranial vasculature.
  • vasculature occlusion devices such as embolic coils
  • catheter delivery systems In such systems used to treat cranial aneurysms, the distal end of an embolic coil delivery catheter is inserted into non-cranial vasculature of a patient, typically through a femoral artery in the groin, and guided to a predetermined delivery site within the cranium.
  • embolic coils of various lengths generally approximately 1 cm to as long as approximately 100 cm, and preselected stiffness often are packed sequentially within a cranial aneurysm to limit blood flow therein and to encourage embolism formation.
  • physicians first utilize stiffer coils to establish a framework within the aneurysm and then select more flexible coils to fill spaces within the framework.
  • each coil conforms both to the aneurysm and to previously implanted coils.
  • Each successive coil is selected individually based on factors including stiffness, length, and preformed shape which the coil will tend to assume after delivery.
  • each embolic coil During implantation, the physician manipulates each embolic coil until it is in a satisfactory position, as seen by an imaging technique such as fluoroscopic visualization, before detaching the coil from the delivery system. It is beneficial for both ends of each coil to remain positioned within the aneurysm after delivery; otherwise, a length of coil protruding into the main lumen of the blood vessel invites undesired clotting external to the aneurysm. After each successive coil is detached, the next coil is subject to an increasing risk of becoming entangled in the growing mass of coils, thereby restricting the depth of insertion for that coil into the aneurysm.
  • Difficulties may arise due to stretching of the embolic coils during repositioning or attempted retrieval of the coils, especially if the coil becomes entangled and complete insertion of the coil into the aneurysm is not accomplished. If pulling forces applied to a coil exceed its elastic limit, the coil will not return to its original shape. A stretched coil exhibits diminished pushability or retractability, and becomes more difficult to manipulate into an optimal position or to be removed. Moreover, a stretched coil occupies less volume than an unstretched coil, which increases the number of coils needed to sufficiently pack the aneurysm to encourage formation of a robust embolus positioned wholly within the aneurysm. To avoid such problems stretch resistance devices are used, such as that disclosed in U.S. Pat. No. 5,853,418, herein incorporated by reference in its entirety, having a primary coil and an elongated stretch-resisting member fixedly attached to the primary cod in at least MO locations.
  • vaso-occlusive coils In order to deliver the vaso-occlusive coils to a desired site, e.g., an aneurysm, in the vasculature, it is well-known to first position a relatively small profile, delivery catheter or micro-catheter at the targeted site using fluoroscopy, ultrasound, or other method of steerable navigation. A delivery or “pusher” wire is then passed through a proximal end of the catheter lumen, until a vaso-occlusive coil coupled to a distal end of the pusher wire is extended out of the distal end opening of the catheter and into the blood vessel at the targeted site.
  • vaso-occlusive device is then released or detached from the end pusher wire, and the pusher wire is withdrawn in a proximal direction back through the catheter.
  • another occlusive device may then be pushed through the catheter and released at the same site in a similar manner.
  • an electrolytically severable junction which is an exposed section or detachment zone located along a distal end portion of the pusher wire.
  • the detachment zone is typically made of stainless steel and is located just proximal of the vase-occlusive device.
  • An electrolytically severable junction is susceptible to electrolysis and disintegrates when the pusher wire is electrically charged in the presence of an ionic solution, such as blood or other bodily fluids.
  • a current applied to the conductive pusher wire completes a circuit with an electrode attached to the patient's skin, or with a conductive needle inserted through the skin at a remote site, and the detachment zone disintegrates due to electrolysis.
  • Another conventional detachment technique during delivery of a vase-occlusive device involves the use of fluid pressure (e.g., hydraulic detachment) to release an embolic coil once it is properly positioned, as described in U.S. Pat. Nos. 6,063,100 and 6,179,857, each of which is herein incorporated by reference in their entirety.
  • fluid pressure e.g., hydraulic detachment
  • the main problems associated with current detachment schemes are reliability of detachment, speed of detachment, convenience of detaching mechanism (e.g., hydraulic detachment requires a high pressure syringe, while electrolytic detachment requires a battery operated box), and length/stiffness of the distal section.
  • vaso-occlusive device e.g., an embolic coil device
  • An aspect of the present invention relates to an improved heating detachment system for delivery of a vaso-occlusive device that is simpler, more reliable, quicker, more convenient and having a reduced length rigid distal section than that of conventional mechanical detachment systems.
  • Another aspect of the present invention is directed to an improved detachment system for delivery of a vaso-occlusive device that optimizes distal flexibility, placement at a desired treatment site and detachment characteristics.
  • Still another aspect of the present invention relates to a vasculature occlusion device detachment system
  • a heating fuse element having a predetermined resistivity, a first terminating end and an opposite second terminating end.
  • the heating fuse element is made of a material that melts when a current is applied that exceeds a predetermined maximum current threshold.
  • the system further includes an electrically conductive corewire electrically connected proximate its distal end directly to the first terminating end of the heating fuse element at a first electrical connection joint.
  • An insulated electrically conductive wire separate from the electrically conductive corewire is electrically connected directly to the second terminating end of the heating fuse element at a second electrical connection joint.
  • An inner insulation sleeve made from an electrical non-conductive material is placed over a distal section of the corewire and covers the first electrical connection joint.
  • the inner insulation sleeve is disposed between the insulated electrically conductive wire and the electrically conductive corewire.
  • An outer insulation sleeve made from an electrical nonconductive material is disposed over a distal section of an assembly including the insulated electrically conductive wire, the inner insulation sleeve and the electrically conductive corewire.
  • the outer insulation sleeve covers the second electrical connection joint.
  • Yet another aspect of the present invention is directed to a method of using the vasculature occlusion device detachment system in the preceding paragraph.
  • the first terminating end of the heating fuse element is electrically connected directly to the electrically conductive corewire proximate its distal end at the first electrical connection joint.
  • the inner insulation sleeve is positioned over a distal section of the electrically conductive corewire and covering the first electrical connection joint.
  • the second terminating end of the heating fuse element is threaded through the loop of the vasculature occlusion device.
  • a second electrical connection joint is formed by electrically connecting the second terminating end of the heating fuse element to the insulated electrically conductive wire at the second electrical connection joint.
  • the outer insulation sleeve is positioned over a distal section of the assembly and covering the second electrical connection joint.
  • FIG. 1A is a side view of the present inventive fuse heating detachment system for an embolic coil, with a cross-sectional portion of the embolic coil showing the interior thereof:
  • FIG. 1B is a side view of the delivery catheter with the present inventive fuse heating detachment system for an embolic coil assembled therein;
  • FIG. 2A is an enlarged top view of the heating fuse element with reduced localized cross-section, in a closed state prior to activation and application of a current;
  • FIG. 2B is an enlarged top view of the heating fuse element of FIG. 2A , in at open state, after activation of an applied current;
  • FIG. 3 is a schematic electric circuit diagram illustrating a closed loop formed by the power supply, electrically conductive corewire, the insulated electrically conductive wire and the heating fuse element.
  • proximal refers to a direction closer to or away from, respectively, an operator (e.g., surgeon, physician, nurse, technician, etc.) who would insert the medical device into the patient, with the tip-end (i.e., distal end or leading end) of the device inserted inside a patient's body.
  • an operator e.g., surgeon, physician, nurse, technician, etc.
  • tip-end i.e., distal end or leading end
  • the present inventive heating detachment system is utilized for delivery of an embolic component, e.g., embolic helical coil. It is, however, intended and within the scope of the present invention to use the present inventive heating detachment system with any type of vaso-occlusive device.
  • FIG. 1A is a side view of an exemplary fuse heating detachment system in accordance with the present invention for delivery of a vaso-occlusive device, typically a helical embolic coil 5 formed by a series of loops/windings defining a coil lumen 25 .
  • the present inventive detachment system is not limited to embolic coils, but instead is equally suited for any type or shape vaso-occlusive device.
  • Embolic coil 5 has a proximal coil junction 10 located at its proximal end.
  • Proximal coil junction 10 is a joint, preferably made out of at least one of an adhesive, an epoxy and/or a polymer.
  • the joint made of adhesive, epoxy and/or polymer is of relatively low strength and/or relatively low durometer. That is, the relatively low strength of the epoxy/adhesive, or the relatively low durometer of the polymer used to fill that junction (which is related to its tear-out strength) is preferably less than the buckling strength of a delivery catheter used to implant the vaso-occlusive device in a blood vessel.
  • a loop, ring or eyelet 35 extends in a proximal direction from the proximal coil junction 10 of the embolic coil 5 . Preferably, only a single loop, ring or eyelet is provided on the embolic coil.
  • a distal end of the embolic coil 5 is closed off by a distal bead 15 .
  • One or more stretch resistant (SR) members 20 e.g., suture filaments, disposed in the coil lumen 25 provide stretch resistance when excessive pulling forces are applied to the embolic coil 5 during implantation in a patient.
  • each stretch resistant member 20 extends longitudinally the entire length of the coil lumen 25 secured at its respective ends by the proximal coil junction 10 and distal bead 15 to minimize excessive elongation.
  • embolic coil 5 is advanced via delivery catheter 80 to a target site in the body (e.g., within the blood vessel).
  • a target site in the body e.g., within the blood vessel.
  • Corewire 45 has a stiffer proximal section proximate its proximal end compared to its more flexible distal section proximate its distal end.
  • flexibility of the corewire 45 needed to advance the delivery system through distal tortuosity may be achieved by grinding tapers over its distal section, wherein the length and/or number of tapers determines the flexibility of the distal section.
  • the corewire is made from any biocompatible electrically conductive material such as stainless steel or Nitonal.
  • Corewire 45 may be made either as an integrated single piece construction throughout or, alternatively, as a two-piece construction secured, attached, connected or mounted together.
  • the proximal section of the corewire may be a. first material (e.g., stainless steel), while the distal section connected to the proximal section may be made of a second material (e.g., Nitonal) different than the first material.
  • a non-conductive coating (e.g., insulation sleeve) 55 is disposed about the exterior of the corewire 45 .
  • Attached, secured, connected or otherwise mounted to its outer surface and extending preferably the length of the corewire 45 is a separate insulated electrically conductive wire 60 .
  • a heating fuse element 30 having a given resistivity such as an electrical conductive wire or electrical conductive strip is preferably configured as a segment having two terminating ends.
  • heating fuse element 30 is substantially U-shaped or hemispherical. Any other shape is contemplated and within the intended scope of the present invention so long as the heating fuse element 30 is configured as a segment having two terminating ends.
  • heating fuse element 30 has a failure section 65 substantially midway between its terminating ends. Failure section 65 is a mechanically induced deformation and/or reduced diameter (e.g., thinner) cross-section to further increase the localized electrical resistance in this section of the heating fuse element thereby narrowing or targeting the location in which the heating fuse element melts and/or severs.
  • One terminating end 40 of the heating fuse element 30 is electrically connected directly to the distal end of the corewire 45 forming a first electrical connection joint 70 .
  • An inner insulation sleeve 83 made of an electrically non-conductive material is placed over a distal section of the corewire disposed between the insulation sleeve 55 and electrically conductive wire 60 .
  • the inner insulation sleeve 83 protects the first electrical connection joint 70 while also preventing an electrical connection between the second terminating end 50 of the heating fuse element 30 and the corewire 45 .
  • the second terminating end 50 of the heating fuse element 30 is threaded through the loop 35 of the embolic coil 5 .
  • An electrical circuit is completed or closed by electrically connecting the second terminating end 50 of the heating fuse element 30 directly to a stripped distal end of the insulated electrical wire 60 forming a second electrical connection joint 75 .
  • An outer insulation sleeve 85 also made of an electrically non-conductive material, is placed over at least a portion of the insulated conductive wire 60 , the inner insulation sleeve 83 and the corewire 45 .
  • the outer insulation sleeve 85 secures the second electrical connection joint 75 to the insulated conductive wire 60 while protecting the second electrical connection joint 75 itself. Either the same or different electrically non-conductive materials ma be used for the inner and outer insulation sleeves 83 , 85 .
  • a power supply 90 e.g., a battery
  • the conductors i.e., proximal ends of corewire 45 and insulated electrically conductive wire 60
  • a current across the resistive heating fuse element 30 thereby increasing the electrical resistance therein.
  • Each of the first and second electrical connection joints 70 , 75 may be established via solder, welding, conductive epoxy or any other electrical joint connection.
  • the first terminating end 40 of the heating fuse element 30 is electrically connected to the corewire 45 proximate its distal end thereby forming the first electrical joint 70 .
  • Inner insulation sleeve 83 is positioned over a distal section of the electrically conductive corewire 45 while also covering the first electrical connection joint 70 .
  • the second terminating end of 50 of the heating fuse element 30 is then threaded through the loop 35 of the embolic coil 5 . Once threaded through the loop 35 , the second terminating end 50 of the heating fuse element 30 is electrically connected to the insulated electrically conductive wire 60 at the second electrical connection joint 75 .
  • the outer insulation sleeve 85 is positioned over a distal section of the assembly (including the insulated electrically conductive wire 60 , the inner insulation sleeve 83 and the electrically conductive corewire 45 ) and is also positioned to cover the second electrical connection joint 75 .
  • the vasculature occlusion device 5 is advanced via the delivery catheter 80 to a target site in a human body
  • electrical activation of the heating element 30 by the power source (e.g., a battery) 90 increases the electrical resistance therein.
  • the resistance is greatest in the failure section 65 of the beating fuse element 30 .
  • An increase in the resistance in the failure section 65 beyond the predetermined threshold tolerance of the material causes the failure section 65 of the heating fuse element 30 to melt and thus sever thereby releasing the embolic coil 5 secured therein.
  • the delivery catheter 80 , corewire 45 , insulated electrically conductive wire 60 and heating element 30 are withdrawn from the human body by pulling in a proximal direction leaving in place the embolic coil 5 within the blood vessel at its desired treatment site.
  • the present inventive detachment system advantageously minimizes the length (as measured from approximately its midsection to one of its terminating ends) of the heating fuse element 30 .
  • such length of the heating fuse element may be reduced to a range between approximately 1.0 mm to approximate 3.0 mm, preferably approximately 2 mm.
  • the heating fuse element 30 is desirably sufficiently long (as measured in an axial direction) to produce sufficient resistance when the embolic coil 5 is implanted. While on the other hand, the length of the heating element 30 is sufficiently short to minimize micro-catheter kick back (i.e., push back out of aneurysm). A shorter length heating element also optimizes the flexibility of the distal end of the coil delivery system desirable during delivery of the vaso-occlusive device to the target site in the human body.
  • the corewire serves as one of the electrical conductors and the insulated electrically conductive wire as the other electrical conductor in forming a closed loop electrical path along with the power supply and heating fuse element.
  • the corewire also serves the dual function of advancing the vaso-occlusive device in the delivery catheter.
  • a sufficient resistance is produced in the heating fuse element that melts and/or severs at least a section thereof (e.g., the failure section 65 ) thereby releasing the embolic coil at a target site within the body.
  • the present invention has been shown and described for delivery and detachment of an embolic coil.
  • Other vaso-occlusive devices are contemplated and within the scope of the present invention.

Abstract

A vasculature occlusion device detachment system including a heating fuse element made of a material that melts when a current is applied that exceeds a predetermined maximum current threshold. An electrically conductive corewire connected proximate its distal end directly to the heating fuse element at a first electrical connection joint, while a separate insulated electrically conductive wire is electrically connected directly to the heating fuse element at a second electrical connection joint. An inner insulation sleeve placed over a distal section of the corewire covers the first electrical connection joint and is disposed between the insulated electrically conductive wire and the electrically conductive corewire. An outer insulation sleeve is disposed over a distal section of an assembly including the insulated electrically conductive wire, the inner insulation sleeve and the electrically conductive corewire. The outer insulation sleeve covers the second electrical connection joint.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates to vasculature occlusive devices (e.g., embolic coils) for implantation within a blood vessel of a body. In particular, the present invention relates to an improved heating detachment system for an embolic coil delivery system in the treatment of blood vessel disorders.
  • 2. Description of Related Art
  • Vascular disorders and defects such as aneurysms and other arterio-venous malformations are especially difficult to treat when located near critical tissues or where ready access to malformation is not available. Both difficulty factors apply especially to cranial aneurysms. Due to the sensitive brain tissue surrounding cranial blood vessels and the restricted access, it is very challenging and often risky to surgically treat defects of the cranial vasculature.
  • Alternative treatments include vasculature occlusion devices, such as embolic coils, deployed using catheter delivery systems. In such systems used to treat cranial aneurysms, the distal end of an embolic coil delivery catheter is inserted into non-cranial vasculature of a patient, typically through a femoral artery in the groin, and guided to a predetermined delivery site within the cranium.
  • Multiple embolic coils of various lengths, generally approximately 1 cm to as long as approximately 100 cm, and preselected stiffness often are packed sequentially within a cranial aneurysm to limit blood flow therein and to encourage embolism formation. Typically, physicians first utilize stiffer coils to establish a framework within the aneurysm and then select more flexible coils to fill spaces within the framework. Ideally, each coil conforms both to the aneurysm and to previously implanted coils. Each successive coil is selected individually based on factors including stiffness, length, and preformed shape which the coil will tend to assume after delivery.
  • During implantation, the physician manipulates each embolic coil until it is in a satisfactory position, as seen by an imaging technique such as fluoroscopic visualization, before detaching the coil from the delivery system. It is beneficial for both ends of each coil to remain positioned within the aneurysm after delivery; otherwise, a length of coil protruding into the main lumen of the blood vessel invites undesired clotting external to the aneurysm. After each successive coil is detached, the next coil is subject to an increasing risk of becoming entangled in the growing mass of coils, thereby restricting the depth of insertion for that coil into the aneurysm.
  • Difficulties may arise due to stretching of the embolic coils during repositioning or attempted retrieval of the coils, especially if the coil becomes entangled and complete insertion of the coil into the aneurysm is not accomplished. If pulling forces applied to a coil exceed its elastic limit, the coil will not return to its original shape. A stretched coil exhibits diminished pushability or retractability, and becomes more difficult to manipulate into an optimal position or to be removed. Moreover, a stretched coil occupies less volume than an unstretched coil, which increases the number of coils needed to sufficiently pack the aneurysm to encourage formation of a robust embolus positioned wholly within the aneurysm. To avoid such problems stretch resistance devices are used, such as that disclosed in U.S. Pat. No. 5,853,418, herein incorporated by reference in its entirety, having a primary coil and an elongated stretch-resisting member fixedly attached to the primary cod in at least MO locations.
  • In order to deliver the vaso-occlusive coils to a desired site, e.g., an aneurysm, in the vasculature, it is well-known to first position a relatively small profile, delivery catheter or micro-catheter at the targeted site using fluoroscopy, ultrasound, or other method of steerable navigation. A delivery or “pusher” wire is then passed through a proximal end of the catheter lumen, until a vaso-occlusive coil coupled to a distal end of the pusher wire is extended out of the distal end opening of the catheter and into the blood vessel at the targeted site. The vaso-occlusive device is then released or detached from the end pusher wire, and the pusher wire is withdrawn in a proximal direction back through the catheter. Depending on the particular needs of the patient, another occlusive device may then be pushed through the catheter and released at the same site in a similar manner.
  • Several conventional methods are used to detach the wire from the embolic coil once it has been properly positioned at the targeted site in the blood vessel using a delivery catheter. One known way to release a vaso-occlusive coil from the end of the pusher wire is through the use of an electrolytically severable junction, which is an exposed section or detachment zone located along a distal end portion of the pusher wire. The detachment zone is typically made of stainless steel and is located just proximal of the vase-occlusive device. An electrolytically severable junction is susceptible to electrolysis and disintegrates when the pusher wire is electrically charged in the presence of an ionic solution, such as blood or other bodily fluids. Thus, once the detachment zone exits out of the catheter distal end and is exposed in the vessel blood pool of the patient, a current applied to the conductive pusher wire completes a circuit with an electrode attached to the patient's skin, or with a conductive needle inserted through the skin at a remote site, and the detachment zone disintegrates due to electrolysis.
  • One disadvantage of occlusive devices that are deployed using electrolytic detachment is that the electrolytic process requires a certain amount of time to elapse to effectuate release of the occlusive element. This time lag is also disadvantageous for occlusive delivery devices that utilize thermal detachment such as that described in U.S. Pat. No. 6,966,892, which is herein incorporated by reference in its entirety.
  • Another conventional detachment technique during delivery of a vase-occlusive device involves the use of fluid pressure (e.g., hydraulic detachment) to release an embolic coil once it is properly positioned, as described in U.S. Pat. Nos. 6,063,100 and 6,179,857, each of which is herein incorporated by reference in their entirety.
  • The main problems associated with current detachment schemes are reliability of detachment, speed of detachment, convenience of detaching mechanism (e.g., hydraulic detachment requires a high pressure syringe, while electrolytic detachment requires a battery operated box), and length/stiffness of the distal section.
  • It is therefore desirable to develop an improved heating detachment system for a vaso-occlusive device (e.g., an embolic coil device) that solves the aforementioned problems associated with conventional devices.
  • SUMMARY OF THE INVENTION
  • An aspect of the present invention relates to an improved heating detachment system for delivery of a vaso-occlusive device that is simpler, more reliable, quicker, more convenient and having a reduced length rigid distal section than that of conventional mechanical detachment systems.
  • Another aspect of the present invention is directed to an improved detachment system for delivery of a vaso-occlusive device that optimizes distal flexibility, placement at a desired treatment site and detachment characteristics.
  • Still another aspect of the present invention relates to a vasculature occlusion device detachment system including a heating fuse element having a predetermined resistivity, a first terminating end and an opposite second terminating end. The heating fuse element is made of a material that melts when a current is applied that exceeds a predetermined maximum current threshold. The system further includes an electrically conductive corewire electrically connected proximate its distal end directly to the first terminating end of the heating fuse element at a first electrical connection joint. An insulated electrically conductive wire separate from the electrically conductive corewire is electrically connected directly to the second terminating end of the heating fuse element at a second electrical connection joint. An inner insulation sleeve made from an electrical non-conductive material is placed over a distal section of the corewire and covers the first electrical connection joint. The inner insulation sleeve is disposed between the insulated electrically conductive wire and the electrically conductive corewire. An outer insulation sleeve made from an electrical nonconductive material is disposed over a distal section of an assembly including the insulated electrically conductive wire, the inner insulation sleeve and the electrically conductive corewire. The outer insulation sleeve covers the second electrical connection joint.
  • Yet another aspect of the present invention is directed to a method of using the vasculature occlusion device detachment system in the preceding paragraph. The first terminating end of the heating fuse element is electrically connected directly to the electrically conductive corewire proximate its distal end at the first electrical connection joint. Next, the inner insulation sleeve is positioned over a distal section of the electrically conductive corewire and covering the first electrical connection joint. The second terminating end of the heating fuse element is threaded through the loop of the vasculature occlusion device. A second electrical connection joint is formed by electrically connecting the second terminating end of the heating fuse element to the insulated electrically conductive wire at the second electrical connection joint. The outer insulation sleeve is positioned over a distal section of the assembly and covering the second electrical connection joint.
  • BRIEF DESCRIPTION OF THE DRAWING
  • The foregoing and other features of the present invention will be more readily apparent from the following detailed description and drawings of illustrative of the invention wherein like reference numbers refer to similar elements throughout the several views and in which:
  • FIG. 1A is a side view of the present inventive fuse heating detachment system for an embolic coil, with a cross-sectional portion of the embolic coil showing the interior thereof:
  • FIG. 1B is a side view of the delivery catheter with the present inventive fuse heating detachment system for an embolic coil assembled therein;
  • FIG. 2A is an enlarged top view of the heating fuse element with reduced localized cross-section, in a closed state prior to activation and application of a current;
  • FIG. 2B is an enlarged top view of the heating fuse element of FIG. 2A, in at open state, after activation of an applied current; and
  • FIG. 3 is a schematic electric circuit diagram illustrating a closed loop formed by the power supply, electrically conductive corewire, the insulated electrically conductive wire and the heating fuse element.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The terms “proximal”/“proximally” and “distal”/“distally” refer to a direction closer to or away from, respectively, an operator (e.g., surgeon, physician, nurse, technician, etc.) who would insert the medical device into the patient, with the tip-end (i.e., distal end or leading end) of the device inserted inside a patient's body. Thus, for example, a “proximal direction” would refer to the direction towards the operator, whereas “distal direction” would refer to the direction away from the operator towards the leading or tip-end of the medical device.
  • By way of illustrative example only, the present inventive heating detachment system is utilized for delivery of an embolic component, e.g., embolic helical coil. It is, however, intended and within the scope of the present invention to use the present inventive heating detachment system with any type of vaso-occlusive device.
  • FIG. 1A is a side view of an exemplary fuse heating detachment system in accordance with the present invention for delivery of a vaso-occlusive device, typically a helical embolic coil 5 formed by a series of loops/windings defining a coil lumen 25. The present inventive detachment system is not limited to embolic coils, but instead is equally suited for any type or shape vaso-occlusive device. Embolic coil 5 has a proximal coil junction 10 located at its proximal end. Proximal coil junction 10 is a joint, preferably made out of at least one of an adhesive, an epoxy and/or a polymer. Most preferably, the joint made of adhesive, epoxy and/or polymer is of relatively low strength and/or relatively low durometer. That is, the relatively low strength of the epoxy/adhesive, or the relatively low durometer of the polymer used to fill that junction (which is related to its tear-out strength) is preferably less than the buckling strength of a delivery catheter used to implant the vaso-occlusive device in a blood vessel. A loop, ring or eyelet 35 extends in a proximal direction from the proximal coil junction 10 of the embolic coil 5. Preferably, only a single loop, ring or eyelet is provided on the embolic coil. Opposite its proximal end, a distal end of the embolic coil 5 is closed off by a distal bead 15. One or more stretch resistant (SR) members 20, e.g., suture filaments, disposed in the coil lumen 25 provide stretch resistance when excessive pulling forces are applied to the embolic coil 5 during implantation in a patient. Preferably, each stretch resistant member 20 extends longitudinally the entire length of the coil lumen 25 secured at its respective ends by the proximal coil junction 10 and distal bead 15 to minimize excessive elongation.
  • Referring to FIG. 1B, using a corewire or pusher, embolic coil 5 is advanced via delivery catheter 80 to a target site in the body (e.g., within the blood vessel). In contrast to conventional pusher members having a central lumen, there is no central lumen defined longitudinally through the corewire of the present invention. Corewire 45 has a stiffer proximal section proximate its proximal end compared to its more flexible distal section proximate its distal end. As is illustrated in FIG. 1B, flexibility of the corewire 45 needed to advance the delivery system through distal tortuosity may be achieved by grinding tapers over its distal section, wherein the length and/or number of tapers determines the flexibility of the distal section. Thus, the length and/or number of tapers shown in the drawings are merely for illustrative purposes only and may be adapted, as desired. The corewire is made from any biocompatible electrically conductive material such as stainless steel or Nitonal. Corewire 45 may be made either as an integrated single piece construction throughout or, alternatively, as a two-piece construction secured, attached, connected or mounted together. For instance, the proximal section of the corewire may be a. first material (e.g., stainless steel), while the distal section connected to the proximal section may be made of a second material (e.g., Nitonal) different than the first material. A non-conductive coating (e.g., insulation sleeve) 55 is disposed about the exterior of the corewire 45. Attached, secured, connected or otherwise mounted to its outer surface and extending preferably the length of the corewire 45 is a separate insulated electrically conductive wire 60.
  • A heating fuse element 30 having a given resistivity such as an electrical conductive wire or electrical conductive strip is preferably configured as a segment having two terminating ends. Typically, heating fuse element 30 is substantially U-shaped or hemispherical. Any other shape is contemplated and within the intended scope of the present invention so long as the heating fuse element 30 is configured as a segment having two terminating ends. Preferably, heating fuse element 30 has a failure section 65 substantially midway between its terminating ends. Failure section 65 is a mechanically induced deformation and/or reduced diameter (e.g., thinner) cross-section to further increase the localized electrical resistance in this section of the heating fuse element thereby narrowing or targeting the location in which the heating fuse element melts and/or severs.
  • One terminating end 40 of the heating fuse element 30 is electrically connected directly to the distal end of the corewire 45 forming a first electrical connection joint 70. An inner insulation sleeve 83 made of an electrically non-conductive material is placed over a distal section of the corewire disposed between the insulation sleeve 55 and electrically conductive wire 60. The inner insulation sleeve 83 protects the first electrical connection joint 70 while also preventing an electrical connection between the second terminating end 50 of the heating fuse element 30 and the corewire 45. The second terminating end 50 of the heating fuse element 30 is threaded through the loop 35 of the embolic coil 5. An electrical circuit is completed or closed by electrically connecting the second terminating end 50 of the heating fuse element 30 directly to a stripped distal end of the insulated electrical wire 60 forming a second electrical connection joint 75. An outer insulation sleeve 85, also made of an electrically non-conductive material, is placed over at least a portion of the insulated conductive wire 60, the inner insulation sleeve 83 and the corewire 45. The outer insulation sleeve 85 secures the second electrical connection joint 75 to the insulated conductive wire 60 while protecting the second electrical connection joint 75 itself. Either the same or different electrically non-conductive materials ma be used for the inner and outer insulation sleeves 83, 85. In the electrical circuit schematic shown in FIG. 3, a power supply 90 (e.g., a battery) is connected across the conductors (i.e., proximal ends of corewire 45 and insulated electrically conductive wire 60) producing a current across the resistive heating fuse element 30 thereby increasing the electrical resistance therein. Each of the first and second electrical connection joints 70, 75 may be established via solder, welding, conductive epoxy or any other electrical joint connection.
  • In operation, the first terminating end 40 of the heating fuse element 30 is electrically connected to the corewire 45 proximate its distal end thereby forming the first electrical joint 70. Inner insulation sleeve 83 is positioned over a distal section of the electrically conductive corewire 45 while also covering the first electrical connection joint 70. The second terminating end of 50 of the heating fuse element 30 is then threaded through the loop 35 of the embolic coil 5. Once threaded through the loop 35, the second terminating end 50 of the heating fuse element 30 is electrically connected to the insulated electrically conductive wire 60 at the second electrical connection joint 75. Next, the outer insulation sleeve 85 is positioned over a distal section of the assembly (including the insulated electrically conductive wire 60, the inner insulation sleeve 83 and the electrically conductive corewire 45) and is also positioned to cover the second electrical connection joint 75. Now that the delivery device has been assembled, using the electrically conductive corewire 45 the vasculature occlusion device 5 is advanced via the delivery catheter 80 to a target site in a human body Once the embolic coil 5 has been properly positioned at a desired treatment site within the blood vessel, electrical activation of the heating element 30 by the power source (e.g., a battery) 90 increases the electrical resistance therein. Due to its design, the resistance is greatest in the failure section 65 of the beating fuse element 30. An increase in the resistance in the failure section 65 beyond the predetermined threshold tolerance of the material causes the failure section 65 of the heating fuse element 30 to melt and thus sever thereby releasing the embolic coil 5 secured therein. Thereafter, the delivery catheter 80, corewire 45, insulated electrically conductive wire 60 and heating element 30 are withdrawn from the human body by pulling in a proximal direction leaving in place the embolic coil 5 within the blood vessel at its desired treatment site.
  • The present inventive detachment system advantageously minimizes the length (as measured from approximately its midsection to one of its terminating ends) of the heating fuse element 30. For example, with this alternative embodiment such length of the heating fuse element may be reduced to a range between approximately 1.0 mm to approximate 3.0 mm, preferably approximately 2 mm.
  • Additional design factors or considerations are contemplated other than that of maximizing heat transfer to the coil securing suture. On the one hand, the heating fuse element 30 is desirably sufficiently long (as measured in an axial direction) to produce sufficient resistance when the embolic coil 5 is implanted. While on the other hand, the length of the heating element 30 is sufficiently short to minimize micro-catheter kick back (i.e., push back out of aneurysm). A shorter length heating element also optimizes the flexibility of the distal end of the coil delivery system desirable during delivery of the vaso-occlusive device to the target site in the human body.
  • In accordance with the present invention, the corewire serves as one of the electrical conductors and the insulated electrically conductive wire as the other electrical conductor in forming a closed loop electrical path along with the power supply and heating fuse element. Preferably, the corewire also serves the dual function of advancing the vaso-occlusive device in the delivery catheter. In response to current provided by the power supply a sufficient resistance is produced in the heating fuse element that melts and/or severs at least a section thereof (e.g., the failure section 65) thereby releasing the embolic coil at a target site within the body.
  • The present invention has been shown and described for delivery and detachment of an embolic coil. Other vaso-occlusive devices are contemplated and within the scope of the present invention.
  • Thus, while there have been shown, described, and pointed out fundamental novel features of the invention as applied to a preferred embodiment thereof, it will be understood that various omissions, substitutions, and changes in the form and details of the devices illustrated, and in their operation, may be made by those skilled in the art without departing from the spirit and scope of the invention. For example, it is expressly intended that all combinations of those elements and/or steps that perform substantially the same function, in substantially the same way, to achieve the same results be within the scope of the invention. Substitutions of elements from one described embodiment to another are also fully intended and contemplated. It is also to be understood that the drawings are not necessarily drawn to scale, but that they are merely conceptual in nature. It is the intention, therefore, to be limited only as indicated by the scope of the claims appended hereto.
  • Every issued patent, pending patent application, publication, journal article, book or any other reference cited herein is each incorporated by reference in their entirety.

Claims (17)

What is claimed is:
1. A detachment system comprising:
a heating fuse element having a predetermined resistivity; the heating fuse element having a first terminating end and an opposite second terminating end; the heating fuse element being made of a material that melts or severs when an applied current exceeds a predetermined maximum current threshold;
an electrically conductive corewire having a proximal end and an opposite distal end; the electrically conductive corewire being electrically connected proximate its distal end directly to the first terminating end of the heating fuse element at a first electrical connection joint; and
an insulated electrically conductive wire separate from the electrically conductive corewire; the insulated electrically conductive wire having a proximal end and an opposite distal end; the distal end of the insulated electrically conductive wire being electrically connected directly to the second terminating end of the heating fuse element at a second electrical connection joint;
an inner insulation sleeve made from an electrical non-conductive material; the inner insulation sleeve is disposed over a distal section of the corewire and covers the first electrical connection joint; the inner insulation sleeve is disposed between the insulated electrically conductive wire and the electrically conductive corewire; and
an outer insulation sleeve made from an electrical non-conductive material; the outer insulation sleeve is disposed over a distal section of an assembly including the insulated electrically conductive wire, the inner insulation sleeve and the electrically conductive corewire; the outer insulation sleeve, covers the second electrical connection joint.
2. The system in accordance with claim 1, further comprising a power source electrically connected to the respective proximal ends of the electrically conductive corewire and the insulated electrically conductive wire.
3. The system in accordance with claim 1, wherein the heating fuse element is a conductive wire or a conductive strip.
4. The system in accordance with claim 1, wherein the electrically conductive corewire is narrowly tapered from its proximal end towards is distal end.
5. The system in accordance with claim 1, further comprising, a vasculature occlusion device having a proximal end and an opposite distal end; a loop protrudes in a proximal direction from the proximal end of the vasculature occlusion device; the heating fuse element being threaded through the loop.
6. The system in accordance with claim 1, wherein the electrically conductive corewire does not have a lumen defined therein.
7. The system in accordance with claim 1, wherein the heating fuse element is U-shaped or hemispherical in shape.
8. The system in accordance with claim 1, wherein a length of the heating fuse element as measured from its midsection to one of the terminating ends is minimized to maximize resistivity and heating.
9. The system in accordance with claim 1, wherein the heating fuse element is made from a material that maximizes resistivity.
10. The system in accordance with claim 8, wherein the length of the heating fuse element measured from approximately its midsection to one of its terminating ends is between approximately 1 mm and approximately 3 mm.
11. The system in accordance with claim 1, wherein the heating fuse element has a failure section approximately midway between the first terminating end and the second terminating end; the failure section of the heating fuse element having a mechanically induced deformation and/or reduced diameter cross-section to induce failure therein.
12. A method of sing the detachment system n accordance with claim 5, comprising the steps of:
electrically connecting the first terminating end of the heating fuse element to the electrically conductive corewire proximate its distal end at the first electrical connection joint;
positioning the inner insulation sleeve over a distal section of the electrically conductive corewire and covering the first electrical connection joint;
threading the second terminating end of the heating fuse element through the loop of the vasculature occlusion device;
electrically connecting the second terminating end of the heating fuse element to the insulated electrically conductive ye wire at the second electrical connection joint; and
positioning the outer insulation sleeve over a distal section of the assembly and covering, the second electrical connection joint.
13. The method in accordance with claim 12, further comprising the steps of:
advancing the vasculature occlusion device via a delivery catheter through a human body using the electrically conductive corewire;
positioning the vasculature occlusion device at a target site in the human body;
applying an electrical current powered by a power source to the electrically conductive corewire and insulated electrically conductive wire beyond the predetermined maximum current threshold of a portion of the heating fuse element;
as a result of the applied electrical current, increasing, an electrical resistance of the heating fuse element;
generating sufficient heat due to the increased electrical resistance to melt and sever the portion of the heating fuse element thereby releasing the vasculature occlusive device from the heating fuse element; and
withdrawing from the human body by pulling in a proximal direction the delivery catheter, the heating fuse element and the electrically conductive corewire, while leaving at the target site in the human body the vasculature occlusive device.
14. The method in accordance with claim 12, wherein the heating fuse element is U-shaped or hemispherical in shape.
15. The method in accordance with claim 12, wherein a length of the heating fuse element as measured from its midsection to one of the terminating ends is minimized to maximize resistivity and heating.
16. The method in accordance with claim 12, wherein the length of the heating fuse element measured from its midsection to one of its terminating ends is between approximately 1 mm and approximately 3 mm.
17. The method in accordance with claim 12, wherein the heating fuse element has a failure section approximately midway between the first terminating end and the second terminating end; the failure section of the heating fuse element having a mechanically induced deformation and/or reduced diameter cross-section to induce failure therein.
US14/491,145 2014-09-19 2014-09-19 Vasculature occlusion device detachment system with tapered corewire and single loop fuse detachment Active 2035-08-08 US9855050B2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US14/491,145 US9855050B2 (en) 2014-09-19 2014-09-19 Vasculature occlusion device detachment system with tapered corewire and single loop fuse detachment
BR102015023992A BR102015023992A2 (en) 2014-09-19 2015-09-17 Single-loop fused-wire vasculature occlusion device separation system
JP2015184845A JP6768276B2 (en) 2014-09-19 2015-09-18 Vascular occlusion device separation system by separating tapered core wire and single loop fuse
EP15185808.1A EP2997911B1 (en) 2014-09-19 2015-09-18 A vasculature occlusion device detachment system with tapered corewire and heater activated detachment
CA2904928A CA2904928A1 (en) 2014-09-19 2015-09-18 A vasculature occlusion device detachment system with tapered corewire and heater activated fiber detachment
EP20183939.6A EP3738528A1 (en) 2014-09-19 2015-09-18 A vasculature occlusion device detachment system with tapered corewire and single loop fuse detachment
ES15185808T ES2818105T3 (en) 2014-09-19 2015-09-18 Vascular Occlusion Device Retraction System with Tapered Center Lead and Heat Activated Retraction
KR1020150132174A KR102525250B1 (en) 2014-09-19 2015-09-18 A vasculature occlusion device detachment system with tapered corewire and single loop fuse detachment
AU2015227530A AU2015227530B2 (en) 2014-09-19 2015-09-18 A vasculature occlusion device detachment system with tapered corewire and heater activated fiber detachment
CN201510599740.6A CN105434004B (en) 2014-09-19 2015-09-18 A kind of vessel occlusive apparatus disassembling system with taper core wire and monocycle fuse disassembly component
JP2020107599A JP6992130B2 (en) 2014-09-19 2020-06-23 Vascular obstruction device separation system by separating tapered core wire and single loop fuse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14/491,145 US9855050B2 (en) 2014-09-19 2014-09-19 Vasculature occlusion device detachment system with tapered corewire and single loop fuse detachment

Publications (2)

Publication Number Publication Date
US20160081694A1 true US20160081694A1 (en) 2016-03-24
US9855050B2 US9855050B2 (en) 2018-01-02

Family

ID=54150309

Family Applications (1)

Application Number Title Priority Date Filing Date
US14/491,145 Active 2035-08-08 US9855050B2 (en) 2014-09-19 2014-09-19 Vasculature occlusion device detachment system with tapered corewire and single loop fuse detachment

Country Status (9)

Country Link
US (1) US9855050B2 (en)
EP (2) EP3738528A1 (en)
JP (2) JP6768276B2 (en)
KR (1) KR102525250B1 (en)
CN (1) CN105434004B (en)
AU (1) AU2015227530B2 (en)
BR (1) BR102015023992A2 (en)
CA (1) CA2904928A1 (en)
ES (1) ES2818105T3 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220142651A1 (en) * 2020-06-05 2022-05-12 Balt Usa Novel enhanced zero displacement optima® system

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10285710B2 (en) * 2016-06-01 2019-05-14 DePuy Synthes Products, Inc. Endovascular detachment system with flexible distal end and heater activated detachment
US11116509B2 (en) * 2017-11-10 2021-09-14 Avantec Vascular Corporation System and method for delivering an embolic device
CN113749717B (en) * 2020-06-05 2023-09-29 微创神通医疗科技(上海)有限公司 Release device, release system, release method and treatment device
CN113749718B (en) * 2020-06-05 2024-01-26 微创神通医疗科技(上海)有限公司 Release device, release system, release method and treatment device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5522836A (en) * 1994-06-27 1996-06-04 Target Therapeutics, Inc. Electrolytically severable coil assembly with movable detachment point
US20140277092A1 (en) * 2013-03-14 2014-09-18 Stryker Nv Operations Limited Vaso-occlusive device delivery system

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624449A (en) * 1993-11-03 1997-04-29 Target Therapeutics Electrolytically severable joint for endovascular embolic devices
EP0696902B1 (en) 1994-03-03 2005-05-11 Boston Scientific Limited Apparatus for detecting separation of a vasoocclusion device
US5522839A (en) * 1994-09-09 1996-06-04 Pilling Weck Incorporated Dissecting forceps
US5578074A (en) * 1994-12-22 1996-11-26 Target Therapeutics, Inc. Implant delivery method and assembly
DK175166B1 (en) 1995-01-03 2004-06-21 Cook William Europ Method of manufacturing an assembly for placing an embolization coil in the vascular system and such assembly as well as an apparatus for advancing the assembly
US5853418A (en) 1995-06-30 1998-12-29 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
US6013084A (en) 1995-06-30 2000-01-11 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
US6156061A (en) 1997-08-29 2000-12-05 Target Therapeutics, Inc. Fast-detaching electrically insulated implant
US6063100A (en) 1998-03-10 2000-05-16 Cordis Corporation Embolic coil deployment system with improved embolic coil
US6478773B1 (en) 1998-12-21 2002-11-12 Micrus Corporation Apparatus for deployment of micro-coil using a catheter
US6277126B1 (en) 1998-10-05 2001-08-21 Cordis Neurovascular Inc. Heated vascular occlusion coil development system
US6835185B2 (en) 1998-12-21 2004-12-28 Micrus Corporation Intravascular device deployment mechanism incorporating mechanical detachment
US6179857B1 (en) 1999-02-22 2001-01-30 Cordis Corporation Stretch resistant embolic coil with variable stiffness
US6280457B1 (en) 1999-06-04 2001-08-28 Scimed Life Systems, Inc. Polymer covered vaso-occlusive devices and methods of producing such devices
US6458127B1 (en) 1999-11-22 2002-10-01 Csaba Truckai Polymer embolic elements with metallic coatings for occlusion of vascular malformations
US7740637B2 (en) 2000-02-09 2010-06-22 Micrus Endovascular Corporation Apparatus and method for deployment of a therapeutic device using a catheter
US6743251B1 (en) 2000-11-15 2004-06-01 Scimed Life Systems, Inc. Implantable devices with polymeric detachment junction
US6866677B2 (en) 2001-04-03 2005-03-15 Medtronic Ave, Inc. Temporary intraluminal filter guidewire and methods of use
US6953473B2 (en) 2001-12-20 2005-10-11 Boston Scientific Scimed, Inc. Detachable device with electrically responsive element
US7485122B2 (en) 2002-06-27 2009-02-03 Boston Scientific Scimed, Inc. Integrated anchor coil in stretch-resistant vaso-occlusive coils
US7608058B2 (en) 2002-07-23 2009-10-27 Micrus Corporation Stretch resistant therapeutic device
US7331973B2 (en) 2002-09-30 2008-02-19 Avdanced Cardiovascular Systems, Inc. Guide wire with embolic filtering attachment
US7651513B2 (en) 2003-04-03 2010-01-26 Boston Scientific Scimed, Inc. Flexible embolic device delivery system
US20050149108A1 (en) 2003-12-17 2005-07-07 Microvention, Inc. Implant delivery and detachment system and method
US8398693B2 (en) 2004-01-23 2013-03-19 Boston Scientific Scimed, Inc. Electrically actuated medical devices
EP1791590B1 (en) 2004-08-25 2015-07-15 Microvention, Inc. Thermal detachment system for implantable devices
CN101048107A (en) 2004-10-29 2007-10-03 株式会社钟化 Medical wire
US7608089B2 (en) 2004-12-22 2009-10-27 Boston Scientific Scimed, Inc. Vaso-occlusive device having pivotable coupling
US20070100414A1 (en) 2005-11-02 2007-05-03 Cardiomind, Inc. Indirect-release electrolytic implant delivery systems
US7582101B2 (en) 2006-02-28 2009-09-01 Cordis Development Corporation Heated mechanical detachment for delivery of therapeutic devices
CA2649702C (en) 2006-04-17 2014-12-09 Microtherapeutics, Inc. System and method for mechanically positioning intravascular implants
KR20100015520A (en) 2007-03-13 2010-02-12 마이크로 테라퓨틱스 인코포레이티드 An implant including a coil and a stretch-resistant member
WO2009088969A2 (en) 2008-01-04 2009-07-16 Boston Scientific Scimed, Inc. Detachment mechanisms for implantable devices
EP2334242B1 (en) 2008-09-09 2014-11-26 Boston Scientific Scimed, Inc. Composite detachment mechanisms
US20100160944A1 (en) * 2008-12-24 2010-06-24 Boston Scientific Scimed, Inc. Thermally detachable embolic assemblies
WO2010104955A2 (en) 2009-03-13 2010-09-16 Boston Scientific Scimed, Inc. Electrical contact for occlusive device delivery system
KR20130054952A (en) 2010-04-14 2013-05-27 마이크로벤션, 인코포레이티드 Implant delivery device
WO2012109367A1 (en) 2011-02-10 2012-08-16 Stryker Corporation Vaso-occlusive device delivery system
JP5331836B2 (en) 2011-02-21 2013-10-30 コヴィディエン リミテッド パートナーシップ System and method for supplying and deploying an occlusion device in a conduit
US20120330349A1 (en) 2011-06-27 2012-12-27 Jones Donald K Implant delivery and active release system
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
JP2013153810A (en) 2012-01-27 2013-08-15 Terumo Corp Knob treatment device and knob treatment method
US8932318B2 (en) 2012-03-30 2015-01-13 DePuy Synthes Products, LLC Embolic coil detachment mechanism with polymer tether
US9980731B2 (en) 2012-03-30 2018-05-29 DePuy Synthes Products, Inc. Embolic coil detachment mechanism with flexible distal member and coupling union
US9943313B2 (en) 2013-01-03 2018-04-17 Empirilon Technology Llc Detachable coil release system and handle assembly
WO2014150824A1 (en) 2013-03-14 2014-09-25 Stryker Corporation Vaso-occlusive device delivery system
CN203591293U (en) 2013-12-04 2014-05-14 王玉峰 Spring ring system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5522836A (en) * 1994-06-27 1996-06-04 Target Therapeutics, Inc. Electrolytically severable coil assembly with movable detachment point
US20140277092A1 (en) * 2013-03-14 2014-09-18 Stryker Nv Operations Limited Vaso-occlusive device delivery system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Electrical Resitivity and Conductivity" - Wikipedia. Revision of 20 July 2014. Accessed on Wikipedia on 09/15/16 at https://en.wikipedia.org/w/index.php?title=Electrical_resistivity_and_conductivity&diff=617665297&oldid=614492869 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220142651A1 (en) * 2020-06-05 2022-05-12 Balt Usa Novel enhanced zero displacement optima® system

Also Published As

Publication number Publication date
KR102525250B1 (en) 2023-04-26
AU2015227530A1 (en) 2016-04-07
EP2997911B1 (en) 2020-07-29
KR20160034221A (en) 2016-03-29
ES2818105T3 (en) 2021-04-09
CA2904928A1 (en) 2016-03-19
US9855050B2 (en) 2018-01-02
CN105434004B (en) 2019-09-20
EP2997911A1 (en) 2016-03-23
JP2016059815A (en) 2016-04-25
BR102015023992A2 (en) 2016-05-24
EP3738528A1 (en) 2020-11-18
AU2015227530B2 (en) 2019-11-14
JP6992130B2 (en) 2022-01-13
JP2020151543A (en) 2020-09-24
JP6768276B2 (en) 2020-10-14
CN105434004A (en) 2016-03-30

Similar Documents

Publication Publication Date Title
JP6359664B2 (en) Vascular occlusive device delivery system
EP2777545B1 (en) Occlusive device delivery system with mechanical detachment
JP6992130B2 (en) Vascular obstruction device separation system by separating tapered core wire and single loop fuse
US20100234872A1 (en) Electrical contact for occlusive device delivery system
EP2668914A1 (en) Implant system
JP6918880B2 (en) Vascular obstruction device detachment system with tapered core wire and heater activated fiber detachment
KR20180103065A (en) Transplantation systems for vascular grafts and vascular grafts using flexible separation zones
AU2015227527A1 (en) A vasculature occlusion device detachment system with tapered corewire and heater activated fiber detachment

Legal Events

Date Code Title Description
AS Assignment

Owner name: DEPUY SYNTHES PRODUCTS, LLC, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LORENZO, JUAN A.;SLAZAS, ROBERT;REEL/FRAME:033777/0708

Effective date: 20140917

AS Assignment

Owner name: DEPUY SYNTHES PRODUCTS, INC., MASSACHUSETTS

Free format text: CHANGE OF NAME;ASSIGNOR:DEPUY SYNTHES PRODUCTS, LLC;REEL/FRAME:044427/0453

Effective date: 20141219

Owner name: DEPUY SYNTHES PRODUCTS, INC., MASSACHUSETTS

Free format text: CHANGE OF NAME;ASSIGNOR:DEPUY SYNTHES PRODUCTS, LLC;REEL/FRAME:044428/0233

Effective date: 20141219

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 4